Hospiscare, which serves Exeter, central and east Devon, receives just 24 per cent of its funding from the Government and ...
Rozanolixizumab's EU approval for self-administration methods aims to improve patient autonomy and satisfaction by minimizing clinic visits. The phase 3 MG0020 study confirmed the safety and efficacy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback